首页>Cancer Chemotherapy and Pharmacology>Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer
Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer
作者单位：Department of Radiology, Gachon University, Gil Hospital, 1198, Guwol-Dong, Namdong-Gu, Incheon 405[1]Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil[2]Department of General Surgery, Gachon University, Gil Hospital, 1198, Guwol-Dong, Namdong-Gu[3]
换一批
